Home
CRSP
CRSP News

Latest CRISPR Therapeutics AG (CRSP) News on July 30, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) Announces Promising Data From Cardiovascular Disease Programs

Simply Wall St.

a month ago

CRISPR Therapeutics (NasdaqGM:CRSP) Announces Promising Data From Cardiovascular Disease Programs

MT Newswires

a month ago

CRISPR Therapeutics Advances Phase 1 Trials for Cardiovascular Disease Programs

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

GlobeNewswire

a month ago

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

CRISPR Therapeutics AG (CRSP) Stock Moves 1.88%: What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Stock Moves 1.88%: What You Should Know

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

Zacks

a month ago

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Insider Monkey

a month ago

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Is CRISPR Therapeutics AG (NASDAQ:CRSP) Trading At A 45% Discount?

Simply Wall St.

a month ago

Is CRISPR Therapeutics AG (NASDAQ:CRSP) Trading At A 45% Discount?

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

Motley Fool

a month ago

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

The FDA Shake-Up Continues, And Could Impact Genetic Medicines

Investor's Business Daily

a month ago

The FDA Shake-Up Continues, And Could Impact Genetic Medicines

Cathie Wood's Flagship Ark Innovation ETF Is Booming Again. Here's Why.

Investor's Business Daily

a month ago

Cathie Wood's Flagship Ark Innovation ETF Is Booming Again. Here's Why.

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

Zacks

a month ago

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Gene-Editing Stocks Gain on LLY-VERV Deal Announcement

Zacks

a month ago

Gene-Editing Stocks Gain on LLY-VERV Deal Announcement

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

Investor's Business Daily

a month ago

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock?

Zacks

2 months ago

CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock?

CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 16% Stock Price Surge Over Last Month

Simply Wall St.

2 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 16% Stock Price Surge Over Last Month

Morningstar Research

2 months ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

Zacks

2 months ago

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

Morningstar Research

2 months ago

Analyst Report: CRISPR Therapeutics AG

CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?

Zacks

2 months ago

CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?

BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy

Zacks

2 months ago

BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy

Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?

Zacks

2 months ago

Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?

The Best Stocks to Invest $1,000 in Right Now

Motley Fool

2 months ago

The Best Stocks to Invest $1,000 in Right Now

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip

Motley Fool

2 months ago

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

2 months ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Crispr Therapeutics call volume above normal and directionally bullish

TipRanks

2 months ago

Crispr Therapeutics call volume above normal and directionally bullish

3 Top Genomics Stocks to Add to Your Portfolio in 2025

Zacks

2 months ago

3 Top Genomics Stocks to Add to Your Portfolio in 2025

MT Newswires

2 months ago

Mizuho Cuts Price Target on CRISPR Therapeutics to $85 From $99, Keeps Outperform Rating

CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug

CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies

Zacks

2 months ago

CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies

5 Monster Stocks to Hold for the Next 10 Years

Motley Fool

2 months ago

5 Monster Stocks to Hold for the Next 10 Years

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

Motley Fool

2 months ago

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

MT Newswires

2 months ago

CRISPR, Sirius Collaborate on RNA Therapy Targeting Blood Clot Disorders

CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies

GlobeNewswire

2 months ago

CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Motley Fool

2 months ago

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Motley Fool

3 months ago

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

2 Biotech Stocks That Are Screaming Buys in May

Motley Fool

3 months ago

2 Biotech Stocks That Are Screaming Buys in May

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Motley Fool

3 months ago

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

3 Monster Stocks to Hold for the Next 10 Years

Motley Fool

3 months ago

3 Monster Stocks to Hold for the Next 10 Years

CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million

Simply Wall St.

3 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

3 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet

Zacks

3 months ago

Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet

CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

3 months ago

CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations

CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks

Zacks

3 months ago

CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks

We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate

Simply Wall St.

3 months ago

We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

GlobeNewswire

3 months ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

Zacks

3 months ago

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

2 Beaten-Down Stocks With Incredible Upside Potential

Motley Fool

3 months ago

2 Beaten-Down Stocks With Incredible Upside Potential

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Zacks

3 months ago

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Morningstar Research

3 months ago

Analyst Report: CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital

TipRanks

3 months ago

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

MT Newswires

3 months ago

BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

Simply Wall St.

3 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

3 Magnificent Stocks That Could Double or More by 2030

Motley Fool

4 months ago

3 Magnificent Stocks That Could Double or More by 2030

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

4 months ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Motley Fool

4 months ago

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

4 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

Simply Wall St.

4 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

Motley Fool

4 months ago

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

MT Newswires

4 months ago

RBC Cuts Price Target on CRISPR Therapeutics to $38 From $48, Keeps Sector Perform, Speculative Risk

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

4 months ago

Biotech stocks slide as Marks resignation seen being negative for sector

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Investor's Business Daily

4 months ago

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Motley Fool

4 months ago

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks

4 months ago

Intellia Focuses on Pipeline Development Amid Stiff Competition

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

Investor's Business Daily

4 months ago

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Zacks

4 months ago

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Zacks

4 months ago

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Novo gains Lexicon obesity drug; CRISPR COO to step down

BioPharma Dive

4 months ago

Novo gains Lexicon obesity drug; CRISPR COO to step down

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

Simply Wall St.

4 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

MT Newswires

4 months ago

CRISPR Therapeutics COO to Step Down

CRISPR Therapeutics Announces Transition of Chief Operating Officer

GlobeNewswire

4 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Simply Wall St.

4 months ago

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey

4 months ago

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

2 Beaten-Down Stocks to Buy on the Dip

Motley Fool

4 months ago

2 Beaten-Down Stocks to Buy on the Dip

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Investor's Business Daily

4 months ago

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

2 No-Brainer Biotech Stocks to Buy Right Now

Motley Fool

4 months ago

2 No-Brainer Biotech Stocks to Buy Right Now

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

Insider Monkey

4 months ago

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

Zacks

4 months ago

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Insider Monkey

4 months ago

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

Insider Monkey

4 months ago

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

5 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Share on Social Networks: